Study finds Paxlovid reduces hospitalization risk in pediatric COVID-19 patients
A University of Hong Kong study found that treatment with the antiviral drug Paxlovid is linked to a 34% lower risk of hospitalization in COVID-19 patients aged 12-17. The research showed that Paxlovid reduced hospitalization rates and was effective in non-hospitalized pediatric patients with the Omicron variant.